✦ LIBER ✦

PUK14 A HEALTH ECONOMIC EVALUATION OF THE USE OF ERYTHROPOIESIS-STIMULATING AGENTS (ESA) IN PATIENTS WITH RENAL FAILURE TREATED WITH HAEMODIALYSIS

✍ Scribed by LA Van Bellinghen; M Lamotte; M Malfait

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSY27 A HEALTH ECONOMIC EVALUATION OF TH

✍ Chevalier, P; Lamotte, M; Leenaerts, P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PUK10 ECONOMIC IMPACT OF A LOW-PROTEIN D

✍ S de Portu; B Cianciaruso; A Pota; L di Miccio; A Di Palma; A Pisani; LG Mantova 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

The use of erythropoiesis-stimulating ag

✍ Nadine Shehata; Irwin Walker; Ralph Meyer; Adam E Haynes; Kevin Imrie; for the C 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 248 KB

Continued Challenges with the Use of Ery

✍ Ms. Rebecca B. Arbuckle; Ms. Niesha L. Griffith; Dr. Lew M. Iacovelli; Mr. Phili 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

PCN4 ERYTHROPOIESIS STIMULATING AGENTS (

✍ Paladini, L; Clark, O; Clark, LG; Engel, T; Pegoretti, B; Faleiros, E 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PUK15 a Managed Care Cost-Offset Model f

✍ R. Mutell; J.L. Rubin; T.C. Bond; T. Mayne 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB